374
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations

, , &
Pages 51-61 | Received 17 Aug 2011, Accepted 09 Jan 2012, Published online: 20 Feb 2012
 

Abstract

Context: The compatibility studies of moexipril hydrochloride (MOXL), imidapril hydrochloride (IMD), enalapril maleate, (ENA) and lisinopril (LIS) in solid state with magnesium stearate and glyceryl behenate were performed.

Objective: The aim of this study was to detect any possible drug–excipient interactions in order to optimize technological process conditions by the selection of the most adequate lubricant.

Materials and methods: Reversed-phase high-performance liquid chromatography was employed for studying drug–excipient binary mixtures in 1:1 ratio and pure drugs under forced ageing test conditions: temperature 318K (45°C) and relative humidity range of 50.9%–75.4%. The method had been revalidated prior to use. The degradation rate constants for the binary mixtures and pure substances were calculated.

Results: The experimental results evidenced that moexipril and enalapril degradation accorded with autocatalytic-second-order kinetics, imidapril degradation followed first-order reaction mechanism, and LIS followed reversible first-order reaction mechanism. A degradation pathway for each substance was proposed to account for the observed decomposition products. It was determined that moexipril stability decreased threefold in the presence of magnesium stearate indicating an incompatibility − (4.15 ± 0.12) 10−3 compared to (1.43 ± 0.32) 10−6 for moexipril in pure. No interaction between magnesium stearate and the remaining studied compounds was observed. The stability studies of MOXL–glyceryl behenate binary mixture revealed no interaction.

Conclusion: Magnesium stearate and increased relative humidity induce MOXL instability, while glyceryl behenate is an optimal lubricant, and therefore, it is recommended for moexipril-containing solid formulations. However, for the formulations containing moexipril and magnesium stearate, it is suggested to minimize the humidity level during storage.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.